Facebook Twitter Gplus YouTube Google Maps RSS
 
 
Home » Archive for category "Adcetris"

Archive for the ‘Adcetris’ Category:


New Boxed Warning for a Lymphoma Drug, Adcetris (brentuximab vedotin)

[1-13-2012] The U.S. Food and Drug Administration (FDA) is notifying the public that two additional cases of progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection that can result in death, have been reported with the lymphoma drug Adcetris (brentuximab vedotin). Due to the serious nature of PML, a new Boxed Warning highlighting this risk has been

Read More::

 
© Ennis & Ennis, P.A.

Switch to our mobile site